Skip to main content

Navigation group

Type at least 3 characters
859 articles

Articles

Original Research

Published on 17 Jul 2024

Effect of early administration of dexamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome: EARLY-DEX COVID-19 trial

in Infectious Diseases: Pathogenesis and Therapy

  • Anabel Franco-Moreno
  • María Soledad Acedo-Gutiérrez
  • Miguel Ángel Casado-Suela
  • Nicolás Labrador-San Martín
  • María de Carranza-López
  • Fátima Ibáñez-Estéllez
  • Clara Hernández-Blanco
  • José Jiménez-Torres
  • Ignacio Vallejo-Maroto
  • Rodolfo Romero-Pareja
Effect of early administration of dexamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome: EARLY-DEX COVID-19 trial
Frontiers in Medicine
doi 10.3389/fmed.2024.1385833
  • 396 views